Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 4.1
edited by Evdokimos Konstantinidis
on 2021/12/08 12:15
Change comment: There is no comment for this version
To version 5.8
edited by Sarantis Dimitriadis
on 2022/06/07 08:45
Change comment: There is no comment for this version

Summary

Details

Page properties
Author
... ... @@ -1,1 +1,1 @@
1 -XWiki.evdokimosk
1 +XWiki.Sarantis
Content
... ... @@ -1,3 +1,320 @@
1 +(% class="western" lang="en-GB" style="text-align:justify" %)
2 +(% lang="en-US" %)**End user:** A person who ultimately uses or is intended to ultimately use the product, service or process. In living lab project, end user is defined as a primary study participant who voluntarily participates research after giving informed consent to be the subject of the research.
3 +
4 +(% class="western" lang="en-GB" style="text-align:justify" %)
5 +(% lang="en-US" %)**Living lab research infrastructure end user:** A person or organization who(%%) (% lang="en-US" %)purchases or uses living lab research infrastructure services to conduct a specific contract based research and development activity (often focusing on specifically defined end user group). Living lab research infrastructure end user can also be study participant (a.k.a. end user), if living project is focusing on developing living lab services and infrastructure.
6 +
7 +(% class="western" lang="en-GB" style="text-align:justify" %)
8 +(% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 +
10 +* (((
11 +(% lang="en-US" %)**Non-professional end users:**
12 +
13 +* (% lang="en-US" %)**Consumers: **Those who buy goods or services for their own use.
14 +
15 +* (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
16 +)))
17 +
18 +* (((
19 +(% lang="en-US" %)**Professional end users**
20 +
21 +* (% lang="en-US" %)**Health professionals and managers:** A person providing health care treatment and advice based on formal training and experience. Also known as healthcare professional or healthcare worker.
22 +
23 +* (% lang="en-US" %)**Social care workers and managers:** Those providing the practical support to help people cope with the day-to-day business of living based on formal training and experience.
24 +
25 +* (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
26 +)))
27 +
28 +(% class="western" lang="en-GB" %)
29 +(% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
30 +
31 +* (((
32 +(% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
33 +
34 +* (% lang="en-US" %)Tangible equipment and device manufactures
35 +
36 +* (% lang="en-US" %)Health and social service providers
37 +
38 +* (% lang="en-US" %)e-health, IT system and digital technology providers
39 +
40 +* (% lang="en-US" %)Wellbeing and wellness service providers
41 +
42 +* (% lang="en-US" %)Pharmaceutical companies
43 +)))
44 +
45 +* (((
46 +(% lang="en-GB" %)
47 +(% lang="en-US" %)**Public sector organizations:**
48 +
49 +* (% lang="en-US" %)**Local level: **Municipals, cities and other local level public organizations providing e.g. health and social services such as primary health care.
50 +
51 +* (% lang="en-US" %)**Regional level: **e.g.** **Regional** **hospitals providing secondary and tertiary care,** **councils, parliaments, and governments as well as other administrative organizations operating at regional level.
52 +
53 +* (% lang="en-US" %)**National level: **Government agencies, departments or temporary pointed working groups responsible for the specific functions such as health and social services.
54 +
55 +* (% lang="en-US" %)**International level: **European commission departments and agencies as well as other organizations operating at international and transnational level.
56 +
57 +* (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
58 +)))
59 +
60 +* (((
61 +(% lang="en-GB" %)
62 +(% lang="en-US" %)**Education and research organizations:**
63 +
64 +* (% lang="en-US" %)**Higher education institutes:** Universities and Universities of Applied Sciences
65 +
66 +* (% lang="en-US" %)**Other educational institutes** covering early childhood, primary, secondary and tertiary education
67 +
68 +* (% lang="en-US" %)**Public research institutions/organizations** such as technical research centers and government laboratories.
69 +
70 +* (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
71 +)))
72 +
73 +* (((
74 +(% lang="en-GB" %)
75 +(% lang="en-US" %)**Civil society organizations:**
76 +
77 +* (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
78 +)))
79 +
80 +* (((
81 +(% lang="en-GB" %)
82 +(% lang="en-US" %)**Networks and clusters:**
83 +
84 +* (% lang="en-US" %)Company cluster organizations and company networks
85 +* (% lang="en-US" %)International, national, regional and local networks
86 +)))
87 +
88 +(% class="western" lang="en-GB" %)
89 +(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
90 +
91 +(% style="margin-left:auto; margin-right:auto" %)
92 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)(((
93 +(% class="western" lang="en-GB" style="text-align:center" %)
94 +(% lang="en-US" %)**Age or age group**
95 +)))
96 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
97 +(% lang="en-US" %)Specific age range
98 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
99 +
100 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
101 +(% class="western" %)
102 +
103 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((
104 +(% class="western" %)
105 +
106 +)))
107 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
108 +(% class="western" lang="en-GB" %)
109 +(% lang="en-US" %)Elderly
110 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
111 +(% class="western" lang="en-GB" %)
112 +(% lang="en-US" %)Adults
113 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
114 +(% class="western" lang="en-GB" %)
115 +(% lang="en-US" %)Youth
116 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
117 +(% class="western" lang="en-GB" %)
118 +(% lang="en-US" %)Children
119 +)))
120 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
121 +(% class="western" %)
122 +
123 +)))
124 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
125 +(% class="western" lang="en-GB" style="text-align:center" %)
126 +(% lang="en-US" %)**Health status**
127 +)))
128 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
129 +(% class="western" lang="en-GB" %)
130 +(% lang="en-US" %)Healthy
131 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
132 +(% class="western" lang="en-GB" %)
133 +(% lang="en-US" %)Patient
134 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
135 +(% class="western" lang="en-GB" %)
136 +(% lang="en-US" %)Rehabilitant
137 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
138 +(% class="western" lang="en-GB" %)
139 +(% lang="en-US" %)Recovered/Survivor
140 +)))
141 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
142 +(% class="western" %)
143 +
144 +)))
145 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
146 +(% class="western" lang="en-GB" style="text-align:center" %)
147 +(% lang="en-US" %)**A specific disease, disorder or disability**
148 +)))
149 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
150 +(% class="western" lang="en-GB" %)
151 +(% lang="en-US" %)ADHD
152 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
153 +(% class="western" lang="en-GB" %)
154 +(% lang="en-US" %)Dementia
155 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
156 +(% class="western" lang="en-GB" %)
157 +(% lang="en-US" %)Parkinsons’ disease
158 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
159 +(% class="western" lang="en-GB" %)
160 +(% lang="en-US" %)Loneliness and Social Isolation
161 +)))
162 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
163 +(% class="western" lang="en-GB" %)
164 +(% lang="en-US" %)Autism
165 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
166 +(% class="western" lang="en-GB" %)
167 +(% lang="en-US" %)Down syndrome
168 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
169 +(% class="western" lang="en-GB" %)
170 +(% lang="en-US" %)Physical disability
171 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
172 +(% class="western" lang="en-GB" %)
173 +(% lang="en-US" %)Mental health
174 +)))
175 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
176 +(% class="western" lang="en-GB" %)
177 +(% lang="en-US" %)Cardiovascular disease
178 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
179 +(% class="western" lang="en-GB" %)
180 +(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF)
181 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
182 +(% class="western" lang="en-GB" %)
183 +(% lang="en-US" %)Sleep apnea/apnea
184 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
185 +(% class="western" lang="en-GB" %)
186 +(% lang="en-US" %)Mild cognitive impairment
187 +)))
188 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
189 +(% class="western" lang="en-GB" %)
190 +(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD)
191 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
192 +(% class="western" lang="en-GB" %)
193 +(% lang="en-US" %)Language disability
194 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
195 +(% class="western" lang="en-GB" %)
196 +(% lang="en-US" %)Substance abuse (drugs, alcohol)
197 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
198 +(% class="western" lang="en-GB" %)
199 +(% lang="en-US" %)Multiple sclerosis
200 +)))
201 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
202 +(% class="western" lang="en-GB" %)
203 +(% lang="en-US" %)Cognitive disorder (mild, major)
204 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
205 +(% class="western" lang="en-GB" %)
206 +(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation
207 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
208 +(% class="western" lang="en-GB" %)
209 +(% lang="en-US" %)Trauma patient
210 +
211 +(% class="western" lang="en-GB" %)
212 +(% lang="en-US" %)(e.g., a spinal cord injury)
213 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
214 +(% class="western" lang="en-GB" %)
215 +(% lang="en-US" %)Neurodegenerative diseases
216 +)))
217 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
218 +(% class="western" %)
219 +
220 +)))
221 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
222 +(% class="western" lang="en-GB" style="text-align:center" %)
223 +(% lang="en-US" %)**Clients of a specific service**
224 +)))
225 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
226 +(% class="western" lang="en-GB" %)
227 +(% lang="en-US" %)Child welfare
228 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
229 +(% class="western" lang="en-GB" %)
230 +(% lang="en-US" %)Nursing home
231 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
232 +(% class="western" lang="en-GB" %)
233 +(% lang="en-US" %)Employment service
234 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
235 +(% class="western" %)
236 +
237 +)))
238 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
239 +(% class="western" lang="en-GB" %)
240 +(% lang="en-US" %)Early childhood education
241 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
242 +(% class="western" lang="en-GB" %)
243 +(% lang="en-US" %)Home care
244 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
245 +(% class="western" lang="en-GB" %)
246 +
247 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
248 +(% class="western" lang="en-GB" %)
249 +
250 +)))
251 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
252 +(% class="western" %)
253 +
254 +)))
255 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
256 +(% class="western" lang="en-GB" style="text-align:center" %)
257 +(% lang="en-US" %)**Vulnerable groups**
258 +)))
259 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
260 +(% class="western" lang="en-GB" %)
261 +(% lang="en-US" %)Minors/Children
262 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
263 +(% class="western" lang="en-GB" %)
264 +(% lang="en-US" %)Single parents with minor children
265 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
266 +(% class="western" lang="en-GB" %)
267 +(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence
268 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
269 +(% class="western" lang="en-GB" %)
270 +(% lang="en-US" %)Substance users
271 +
272 +(% class="western" lang="en-GB" %)
273 +(% lang="en-US" %)(drugs, alcohol)
274 +)))
275 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
276 +(% class="western" lang="en-GB" %)
277 +(% lang="en-US" %)Disabled people
278 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
279 +(% class="western" lang="en-GB" %)
280 +(% lang="en-US" %)Victims of trafficking in human beings
281 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
282 +(% class="western" lang="en-GB" %)
283 +(% lang="en-US" %)Ethnic minorities and immigrants
284 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
285 +(% class="western" lang="en-GB" %)
286 +(% lang="en-US" %)Isolated people
287 +)))
288 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
289 +(% class="western" lang="en-GB" %)
290 +(% lang="en-US" %)Elderly people
291 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
292 +(% class="western" lang="en-GB" %)
293 +(% lang="en-US" %)Persons with serious illnesses
294 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
295 +(% class="western" lang="en-GB" %)
296 +(% lang="en-US" %)Homeless people
297 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
298 +(% class="western" lang="en-GB" %)
299 +(% lang="en-US" %)Ex-prisoners and people with criminal background
300 +)))
301 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; text-align:left; vertical-align:middle; width:153px" %)(((
302 +(% class="western" lang="en-GB" %)
303 +(% lang="en-US" %)Pregnant women
304 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
305 +(% class="western" lang="en-GB" %)
306 +(% lang="en-US" %)Persons with mental disorders
307 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
308 +(% class="western" lang="en-GB" %)
309 +
310 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
311 +(% class="western" lang="en-GB" %)
312 +
313 +)))
314 +
315 +(% class="western" lang="en-GB" %)
316 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
317 +
1 1  |**Researcher expertise**|**Brief use case description**
2 2  |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making
3 3  |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)
XWiki.XWikiComments[0]
Comment
... ... @@ -1,0 +1,5 @@
1 +I think in general, the title 'Customer segments' is confusing. When I think customers of living lab methodologies, I think about businesses, healthcare organizations, public authorities, universities... and not about the researchers.
2 +
3 +Shouldn't the title rather be 'Research fields for H&W Living Labs'?
4 +
5 +Also, for the same reason, I do not understand the link with the title 'Living Lab Business model'. Not the researchers but the actual users of the living lab activities (cf. above) are crucial in the business model, as they (should) pay for the living lab services and gain interest and insights from them)
Date
... ... @@ -1,0 +1,1 @@
1 +2022-01-10 15:43:06.877
Selection
... ... @@ -1,0 +1,1 @@
1 +Researcher expertise
State
... ... @@ -1,0 +1,1 @@
1 +SAFE
Target
... ... @@ -1,0 +1,1 @@
1 +Living Lab Business Model.Customer segments in Health and Wellbeing Living Labs.WebHome

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project